Sort   by:  
 Page size 
UnknownLPS decreases CFTR open probability and mucociliary transport through generation of reactive oxygen species.
Not available
S-EPMC8129928 | biostudies-literature
UnknownAn Ancient CFTR Ortholog Informs Molecular Evolution in ABC Transporters.
Not available
S-EPMC7665244 | biostudies-literature
UnknownActivated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung.
Not available
S-EPMC6368091 | biostudies-literature
UnknownThe glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models.
Not available
S-EPMC4097176 | biostudies-literature
UnknownAlterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor.
Not available
S-EPMC4567518 | biostudies-literature
UnknownEmpire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis.
Not available
S-EPMC8649042 | biostudies-literature
UnknownAntisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation.
Not available
S-EPMC8464507 | biostudies-literature
UnknownA prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
Not available
S-EPMC12056793 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
Sort   by:  
 Page size